Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  brequinar
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-8 of 8 for your search:
Start Over
A Phase I/II Clinical Trial of Brequinar plus Fluorouracil in Patients with Refractory Solid Tumors (Summary Last Modified 08/91)
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 to 80
Sponsor:
Protocol IDs: YALE-HIC-5506, NCI-V91-0051
Phase II Chemotherapy with DuP-785 in Patients with Adenocarcinoma of the Pancreas (Summary Last Modified 06/89)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor:
Protocol IDs: EORTC-16871P
Phase II Chemotherapy with DuP-785 in Patients with Advanced Breast Cancer (Summary Last Modified 03/89)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 74
Sponsor:
Protocol IDs: EORTC-16871B
Phase II Chemotherapy with DuP-785 in Patients with Advanced Colorectal Cancer (Summary Last Modified 03/89)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 19 to 74
Sponsor:
Protocol IDs: EORTC-16871C
Phase II Chemotherapy with DuP-785 in Patients with Advanced Renal Adenocarcinoma (Summary Last Modified 03/89)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor:
Protocol IDs: EORTC-16871K
Phase II Chemotherapy with DuP-785 in Patients with Advanced Malignant Melanoma (Summary Last Modified 03/89)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor:
Protocol IDs: EORTC-16871M
Phase II Chemotherapy with Brequinar Sodium (DuP 785) Administered on a Once-Weekly Schedule in Patients with Advanced Solid Tumors (Summary Last Modified 05/90)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 80
Sponsor:
Protocol IDs: YALE-HIC-5218, NCI-V89-0234
Start Over